Molecular Biomarkers in Sinonasal Cancers: New Frontiers in Diagnosis and Treatment
Open Access
- 20 January 2022
- journal article
- review article
- Published by Springer Nature in Current Oncology Reports
- Vol. 24 (1) , 55-67
Abstract
Purpose of Review: Sinonasal tumors are rare and heterogeneous diseases which pose challenges in diagnosis and treatment. Despite significant progress made in surgical, oncological, and radiotherapy fields, their prognosis still remains poor. Therefore, alternative strategies should be studied in order to refine diagnosis and improve patient care. Recent Findings: In recent years, in-depth molecular studies have identified new biological markers, such as genetic abnormalities and epigenetic variations, which have allowed to refine diagnosis and predict prognosis. As a consequence, new histological entities have been described and specific subgroup stratifications within the well-known histotypes have been made possible. These discoveries have expanded indications for immunotherapy and targeted therapies in order to reduce tumor spread, thus representing a valuable implementation of standard treatments. Summary: Recent findings in molecular biology have paved the way for better understanding and managing such rare and aggressive tumors. Although further efforts need to be made in this direction, expectations are promising.Keywords
This publication has 121 references indexed in Scilit:
- Human Papillomavirus–related Carcinoma With Adenoid Cystic–like FeaturesAmerican Journal of Surgical Pathology, 2013
- Detection of HEY1‐NCOA2 fusion by fluorescence in‐situ hybridization in formalin‐fixed paraffin‐embedded tissues as a possible diagnostic tool for mesenchymal chondrosarcomaPathology International, 2012
- Low-grade Sinonasal Sarcoma With Neural and Myogenic FeaturesAmerican Journal of Surgical Pathology, 2012
- Sinonasal carcinomas: Recent advances in molecular and phenotypic characterization and their clinical implicationsCritical Reviews in Oncology/Hematology, 2011
- Low-grade nonintestinal sinonasal adenocarcinoma: a diagnosis of exclusionAnnals of Diagnostic Pathology, 2011
- New developments in the molecular pathogenesis of head and neck tumors: a review of tumor-specific fusion oncogenes in mucoepidermoid carcinoma, adenoid cystic carcinoma, and NUT midline carcinomaAnnals of Diagnostic Pathology, 2011
- Hamartomas, teratomas and teratocarcinosarcomas of the head and neck: Report of 3 new cases with clinico-pathologic correlation, cytogenetic analysis, and review of the literatureBMC Ear, Nose and Throat Disorders, 2008
- Genetic analysis of sinonasal adenocarcinoma phenotypes: distinct alterations of histogenetic significanceLaboratory Investigation, 2005
- Prediction of TP53 Status for Primary Cisplatin, Fluorouracil, and Leucovorin Chemotherapy in Ethmoid Sinus Intestinal-Type AdenocarcinomaJournal of Clinical Oncology, 2004
- Intestinal-Type Adenocarcinoma of the Nasal Cavity and Paranasal SinusesAmerican Journal of Surgical Pathology, 1986